Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2010
04/01/2010US20100080828 Immunogenic sequences
04/01/2010US20100080824 A formulation comprising a cell culture extract of an isolated virus is identified to be morphologically and phylogenetically similar to the known member of coronaviruses; kits comprising containers containing the formulation used in medical diagnosis, as vaccines and antibodies
04/01/2010US20100080819 Modulators of p-selectin glycoprotein ligand 1
04/01/2010US20100080809 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof
04/01/2010US20100080804 Methods of treating inflammatory disorders of the lungs
04/01/2010US20100080799 Wstf regulates the dna damage response of h2a.x via novel tyrosine kinase activity
04/01/2010US20100080793 DcR3 polypeptide, A TNFR homolog
04/01/2010US20100080784 Methods for treating cachexia and lymphopenia
04/01/2010US20100080780 Pluripotent autologous stem cells from oral mucosa and methods of use
04/01/2010US20100078324 Electrochemical cell
04/01/2010DE102008059985B3 Real-Time-PCR mittels Gigahertz- oder Terahertz-Spektrometrie Real-time PCR using gigahertz or terahertz spectroscopy
04/01/2010DE102008049601A1 Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay Antibodies for determination of prothrombin fragment F2 / F1 + 2 in a homogeneous immunoassay
04/01/2010DE102006021761B4 Biomolekulare Recheneinheit Biomolecular computing unit
04/01/2010DE102006021493B4 Massenspektrometrische Messung mikrobieller Resistenzen Mass spectrometric measurement of microbial resistance
04/01/2010DE102005060925B4 Verfahren zur Detektion von DNA-Basensequenzveränderungen A method for detecting DNA base sequence changes
04/01/2010CA2776044A1 Screening methods for identifying specific staphylococcus aureus inhibitors
04/01/2010CA2743354A1 Oligonucleotidic sequences able to silence the expression of the cyclin d1 -trop2 chimera and uses thereof in medical field
04/01/2010CA2739171A1 Biomarker for microdomain diease
04/01/2010CA2738474A1 Soybean transgenic event mon87705 and methods for detection thereof
04/01/2010CA2738427A1 A method of detecting antibodies and antibody-hiv virion complexes
04/01/2010CA2738287A1 Method for detecting analytes
04/01/2010CA2738264A1 Kits and devices for detecting analytes
04/01/2010CA2738207A1 In vitro method and kit for prognosis or prediction of the response of rheumatoid arthritis patients to treatment with tnf-alpha factor blocking agents
04/01/2010CA2738129A1 Aptamer for ngf and use thereof
04/01/2010CA2737903A1 Methods for identifying the habitats of insects
04/01/2010CA2737795A1 Nitrogen responsive early nodulin gene
04/01/2010CA2737669A1 Combinatorial synthesis and use of libraries of short expressed nucleic acid sequences for the analysis of cellular events
04/01/2010CA2737031A1 Indole and indoline derivatives and methods of use thereof
04/01/2010CA2736373A1 Methods for treating, diagnosing, and monitoring lupus
03/2010
03/31/2010EP2169403A1 Method of measuring microparticles having nucleic acid and apparatus therefor
03/31/2010EP2169078A1 Methods and kits for the diagnosis and the staging of colorectal cancer
03/31/2010EP2169077A1 Methods and compositions for diagnosing an adenocarcinoma
03/31/2010EP2169076A2 Enzymes having alpha amylase activity and methods of use thereof
03/31/2010EP2169059A1 Means and methods for counteracting, preventing and/or determining fibrosis or a risk of fibrosis
03/31/2010EP2169056A1 Set of yeast cells, method of identifying target candidate molecule, method of analyzing action mechanism and screening method
03/31/2010EP2169051A1 Method for induction of differentiation of es cell
03/31/2010EP2169047A2 Microbial detection assembly
03/31/2010EP2168973A1 Nucleic acid ligand complexes
03/31/2010EP2168949A1 Method for electrochemical detection of sequences of nucleic acids
03/31/2010EP2168499A1 Method for acquiring biological rhythm information
03/31/2010EP2167978A2 Method for determining von willebrand factor activity in the absence of ristocetin and for determining the adamts-13 protease
03/31/2010EP2167970A2 Aminoacylase 1 assay method for the in vitro diagnosis of colorectal cancer
03/31/2010EP2167968A1 Method for the multiplex serological diagnosis in vitro of spirochete infections
03/31/2010EP2167692A2 Cd44 splice variants in neurodegenerative diseases
03/31/2010EP2167690A2 Androgen-dependent 1-f-aromatase reporter gene
03/31/2010EP2167689A2 Recurrent gene fusions in prostate cancer
03/31/2010EP2167688A1 Targeted cell death
03/31/2010EP2167687A2 Biomarkers for predicting anti-tnf responsiveness or non-responsiveness
03/31/2010EP2167686A1 Compositions
03/31/2010EP2167685A1 Method and probe/primer system for the "real time" detection of a nucleic acid target
03/31/2010EP2167684A2 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds)
03/31/2010EP2167683A2 Method to predict or diagnose a gastrointestinal disorder or disease
03/31/2010EP2167682A1 System substitute pcr
03/31/2010EP2167681A1 Treatment of cardiovascular disease with salicylates
03/31/2010EP2167680A1 Device and a method for the detection and amplification of a signal
03/31/2010EP2167679A2 Compositions and methods for diagnosing and assesing inflammatory myopathies
03/31/2010EP2167678A2 A method of detecting and separating serum gamma-glutamyl transferase (ggt) isoforms in a sample of biological fluid and the enzyme isoforms thereby obtained
03/31/2010EP2167677A2 Target enzyme in the treatment of acne
03/31/2010EP2167676A1 Combined method and kit for the sequential measurement of (1) the enzymatically active fraction and (2) the total amount of an enzyme
03/31/2010EP2167659A2 Genetic markers associated with endometriosis and use thereof
03/31/2010EP2167634A2 Arrays, substrates, devices, methods and systems for detecting target molecules
03/31/2010EP2167524A1 Methods of directly amplifying nucleic acids from crude samples
03/31/2010EP2167519A1 Nucleic acid packaging system
03/31/2010EP2167075A1 Mixed lineage kinases and metabolic disorders
03/31/2010EP2167057A1 Pde inhibitors for the treatment of hearing impairment
03/31/2010EP1793004B1 Method of forming signal probe polymer
03/31/2010EP1680517B1 Concatameric ligation products: compositions, methods and kits for same
03/31/2010EP1530724B1 Diagnosis and prevention of cancer cell invasion
03/31/2010EP1379126B9 Novel endophytic fungi and methods of use
03/31/2010EP1194168B1 Methods and products for manipulating uncoupling protein expression
03/31/2010CN101688861A Reaction vessel with integrated optical and fluid control elements
03/31/2010CN101688859A modulation of sperm motility
03/31/2010CN101688327A Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death
03/31/2010CN101688253A antitoxin destabilization technology
03/31/2010CN101688252A In vivo expression analysis using ultrasound-induced transfection of reporter constructs
03/31/2010CN101688251A Methods and compositions related to riboswitches that control alternative splicing and rna processing
03/31/2010CN101688250A Nucleic-acid amplification judging method and nucleic-acid amplification judging device
03/31/2010CN101688249A Increasing grain yield through targeted reduction in ethylene signaling
03/31/2010CN101688248A Androgen-dependent gene fusion comprising the 1f aromatase promoter and a reporter gene
03/31/2010CN101688247A methods and compositions for diagnosing osteoarthritis in a feline
03/31/2010CN101688246A Synthetic expression vectors for insect cells
03/31/2010CN101688245A Methods for diagnosing ischemia
03/31/2010CN101688244A Stable recombinant adenosine deaminase
03/31/2010CN101688243A Involvement of lipid kinase, and signal transduction pathway comprising said lipid kinase, in resistance to her2-targeting therapy
03/31/2010CN101688242A primers for detecting plasmodium
03/31/2010CN101688241A Cultures with improved phage resistance
03/31/2010CN101688240A Predicting post-treatment survival in cancer patients with micrornas
03/31/2010CN101688239A Early detection and prognosis of colon cancers
03/31/2010CN101688238A Methods of producing haploid and doubled haploid oil palms
03/31/2010CN101688237A Circular chromosome conformation capture (4c)
03/31/2010CN101688236A Methods of determining lethality of pathogens and malignancies involving replikin peak genes
03/31/2010CN101688235A Method for measuring the plasmine activity of microparticles present in a sample of a biological fluid and use thereof
03/31/2010CN101688234A Methods for modulating lrrk2
03/31/2010CN101688233A Method of bioassaying yokkansan
03/31/2010CN101688232A Biochip for quantifying amino acid and method for analying amino acid using the same
03/31/2010CN101688231A Allosteric trans-splicing group i ribozyme whose activity of target-specific rna replacement is controlled by theophylline
03/31/2010CN101688230A Method for screening immune modulator
03/31/2010CN101688219A Novel herbicide resistance genes
03/31/2010CN101688213A Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
03/31/2010CN101688207A A gastric carcinoma gene znf312b, a protein translated from the gene, and a diagnostic kit and a screening method for anticancer agents using the same